IMMUNOPRECISE ANTIBODIES LTD

IPA XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

96M

Short interest (Aug 29)

0.8%

Net Short (Sep 03 ): -0.1%

Borrow Fee

0.88%

↓ 41.1%

Available Shares

500K

↓ 14.7%

Price Chart

Company Overview

ImmunoPrecise Antibodies Ltd is an AI-driven biotherapeutic research, technology and scientifically robust life science company focused on the discovery and development of next-generation biologics. The Company combines scientific expertise with proprietary technologies such as its LENSai platform to accelerate drug discovery and improve decision-making across complex biological systems. IPA has several subsidiaries in North America and Europe, supporting global partners in advancing novel therapeutics, diagnostics, and translational research.

Company Info

Exchange: NASDAQ

CIK: 0001715925

Asset Type: CS

Market Data

Market Cap: $95,539,024

Employees: 102

Status: Active

Short Interest

Current Borrow Fee 0.88%

Range: 0.63% - 0.88%

Available Shares 500K

Range: 500K - 1M

Recent Changes

Fee Change: ↓ 64.1%

Available Change: ↑ 40.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime